Direct-acting antiviral agents and the path to interferon independence.
about
Hepatitis C genotype 4: The past, present, and futureFinally sofosbuvir: an oral anti-HCV drug with wide performance capabilityPersistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma.Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation ProgramHCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human HepatocytesThe natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia.New prospects for the treatment and prevention of hepatitis C in children.Hepatitis B and C in pregnancy: a review and recommendations for care.Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.Hepatitis C-related liver cirrhosis - strategies for the prevention of hepatic decompensation, hepatocarcinogenesis, and mortalityOptimal interferon-free therapy in treatment-experienced chronic hepatitis C patients.Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace.Interferon-free regimens and direct-acting antiviral agents.A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene.Potential ultrastructure predicting factors for hepatocellular carcinoma in HCV infected patients.Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
P2860
Q26775815-A2FA496F-9318-49AD-B2F6-6D3939C86AD8Q26822400-937EAF99-8F58-4D55-A1CF-241C29096F41Q34289969-B6EEF1E3-39F2-483A-BD7E-511DEF3842D4Q34577157-8A7064E4-D2E9-43EF-A0BC-37A5BD99D861Q35619104-C644F536-AFE8-4F6C-8FA4-C7921DAE5613Q35752660-8C64BD29-3C1F-4503-B97C-C8F4C02EEEE3Q36240265-8B3146D2-DF17-4BFC-8893-BFBBA6FD5B9DQ36538481-E1561167-4798-44CA-8F78-2C601AF6EDC0Q36608054-95CF5E49-670E-4BD3-A90E-78270929774EQ36649138-9A34DF07-401B-42C4-AA46-752CCDBCFDD5Q37029846-001BEBA0-5E84-47D2-B649-69FBDC708742Q38198618-11692F41-329F-4373-A957-B50A26F8BB48Q38295831-79E34145-2D5F-4EEF-896C-9E7ED5F9EB49Q38515906-AF27F81D-29D2-462B-82E9-5A4F1D8DFC0DQ38832897-3C71BFB0-3A0F-4D36-A856-DB4D8F26A539Q38848401-CB5AB1EF-F489-4FFD-9ABE-F4197C637178Q39212821-31D424B3-EC25-4D83-8006-761D5647C0B9Q39867681-4888EBAC-EAE0-49CA-B921-3ACBDCC979B3Q41672361-036C5065-DD58-4858-B0B7-EB45CFECB9AE
P2860
Direct-acting antiviral agents and the path to interferon independence.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Direct-acting antiviral agents and the path to interferon independence.
@ast
Direct-acting antiviral agents and the path to interferon independence.
@en
type
label
Direct-acting antiviral agents and the path to interferon independence.
@ast
Direct-acting antiviral agents and the path to interferon independence.
@en
prefLabel
Direct-acting antiviral agents and the path to interferon independence.
@ast
Direct-acting antiviral agents and the path to interferon independence.
@en
P2093
P2860
P1476
Direct-acting antiviral agents and the path to interferon independence.
@en
P2093
David L Thomas
David R Nelson
Jean-Michel Pawlotsky
Kenneth E Sherman
Raymond T Chung
Warren N Schmidt
P2860
P304
P356
10.1016/J.CGH.2013.06.024
P407
P577
2013-07-18T00:00:00Z